Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
join a community of scientists, engineers, and researchers in an effort to develop medical clinical decision support systems utilizing extended reality technology. You will participate in various
-
at: https://www.nasa.gov/oiir/export-control . Eligibility is currently open to: U.S. Citizens; U.S. Lawful Permanent Residents (LPR); Foreign Nationals eligible for an Exchange Visitor J-1 visa status; and
-
? As an ORISE participant, you will join a community of scientists, engineers, and researchers focused on developing medical clinical decision support systems utilizing extended reality technology. You
-
, vaccines, allergenics, tissues, and cellular and gene therapies. Research Project: This research project focuses on advancing the development and manufacturing of CRISPR/Cas9-edited hematopoietic stem cell
-
, allergenics, tissues, and cellular and gene therapies. Research Project: The candidates will contribute to projects focused on the development and validation of regulatory-relevant preclinical disease models
-
mapping agency, USGS collects, monitors, analyzes, and provides science about natural resource conditions, issues, and problems. Research Project: The participant will be researching code development and
-
to cross international boundaries and present a risk to U.S. livestock. The fellow will have the opportunity to contribute to the development of novel insecticides targeting arthropod pests of livestock
-
technologies required to make that future possible. We’ve long touted our success in developing the technologies that took on acid rain in the 1970s and mercury in the early 2000s. Program Goals The NETL
-
touted our success in developing the technologies that took on acid rain in the 1970s and mercury in the early 2000s. Program Goals The Professional Internship Program is designed to introduce
-
, pharmacovigilance, pharmacoepidemiology methods development). In general you will have opportunities to learn: Understanding of pharmacovigilance workflows; GenAI based algorithm and agent development for causality